Evidence map›Paper›PMID 40621927›Full record

ArticleMicrobiology spectrum2025

Ye Shiqing, Lu Xinjie, Zhu Xiaotong, Chen Jiayan, Lu Jiahai, Chen Xiaodong, Lou Yongliang, Li Xiang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Opposite regulatory effects ofFrontiers in neurology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ye Shiqing *Wenzhou Key Laboratory of Sanitary Microbiology, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Lu Xinjie *Wenzhou Key Laboratory of Sanitary Microbiology, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Zhu XiaotongWenzhou Key Laboratory of Sanitary Microbiology, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Chen JiayanWenzhou Key Laboratory of Sanitary Microbiology, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Lu JiahaiWenzhou Key Laboratory of Sanitary Microbiology, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Chen XiaodongDepartment of Neurology, Linyi Women & Children's Healthcare Hospital, The First Affiliated Hospital of Shandong Medical College, Linyi, Shandong, China.ORCID 0000-0002-1957-2389
Lou YongliangWenzhou Key Laboratory of Sanitary Microbiology, Wenzhou Medical University, Wenzhou, Zhejiang, China.ORCID 0000-0003-4198-0001
Li XiangWenzhou Key Laboratory of Sanitary Microbiology, Wenzhou Medical University, Wenzhou, Zhejiang, China.ORCID 0000-0001-6346-1574

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The amyloid deposition-to-cognitive impairment pathway is crucial in Alzheimer's disease (AD) pathogenesis, with gut microbes influencing its development. Our study evaluated

Indexed as

Alzheimer DiseaseClostridium butyricumCognitionGastrointestinal MicrobiomeProbioticsAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsBrainCognitive DysfunctionColonCytokinesDisease Models, AnimalMaleMiceMice, TransgenicAmyloid beta-PeptidesAmyloid beta-Protein PrecursorCytokinesPresenilin-1Alzheimer’s diseaseClostridium butyricumintestinal microbiotaneuroinflammationshort-chain fatty acid

Identifiers

PMID40621927
PMCPMC12323352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.